{"Ticker": "CVS", "Company": "CVS Health", "Sector": "Health Care", "Updated": "2021-12-30 12:06:19", "Rating": [{"Date": "2021-12-14", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Buy", "Target_Change": "$121"}, {"Date": "2021-12-01", "Rating": "Initiated", "Organization": "Seaport Research Partners", "Rating_Change": "Buy", "Target_Change": "$110"}, {"Date": "2021-05-19", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$89"}, {"Date": "2021-03-17", "Rating": "Downgrade", "Organization": "Guggenheim", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2021-01-08", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Buy", "Target_Change": "$90"}, {"Date": "2020-09-17", "Rating": "Initiated", "Organization": "Piper Sandler", "Rating_Change": "Overweight", "Target_Change": "$72"}, {"Date": "2020-07-01", "Rating": "Initiated", "Organization": "SVB Leerink", "Rating_Change": "Mkt Perform", "Target_Change": "$72"}, {"Date": "2020-05-14", "Rating": "Upgrade", "Organization": "Credit Suisse", "Rating_Change": "Neutral to Outperform", "Target_Change": "$75"}, {"Date": "2019-09-27", "Rating": "Resumed", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$85"}, {"Date": "2019-09-12", "Rating": "Initiated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": ""}, {"Date": "2019-06-05", "Rating": "Upgrade", "Organization": "Standpoint Research", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2019-04-29", "Rating": "Downgrade", "Organization": "Credit Suisse", "Rating_Change": "Outperform to Neutral", "Target_Change": "$73 to $61"}, {"Date": "2019-04-18", "Rating": "Initiated", "Organization": "Guggenheim", "Rating_Change": "Buy", "Target_Change": ""}, {"Date": "2019-04-15", "Rating": "Downgrade", "Organization": "Oppenheimer", "Rating_Change": "Outperform to Perform", "Target_Change": ""}, {"Date": "2019-04-10", "Rating": "Reiterated", "Organization": "BofA/Merrill", "Rating_Change": "Buy", "Target_Change": "$82 to $74"}, {"Date": "2019-03-13", "Rating": "Initiated", "Organization": "Bernstein", "Rating_Change": "Outperform", "Target_Change": ""}, {"Date": "2019-02-20", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Outperform to Market Perform", "Target_Change": "$104 to $68"}, {"Date": "2019-01-17", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$75"}, {"Date": "2018-12-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$91"}, {"Date": "2018-11-29", "Rating": "Resumed", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": "$87"}]}